Literature DB >> 936976

Considerations on the morphogenesis of target and targetoid fibres based on morphometric investigations.

H P Schmitt.   

Abstract

A man of 68, who died from a second heart stroke had neurogenic atrophy of the legs. The anterior tibial muscle showed abundant target and targetoid fibres. Half a year prior to death he had increasing weakness and wasting of the legs. The morphometric evaluation of the target and targetoid fibres showed a considerable independence of the plane size of the single zones from the total gauge of the fibres on cross section. Only a small part of the variation in size of zone 2 (4%) depended on the size of the target, indicating that zone 2 cannot just be a passive product of a shrinkage and disappearance of the target, but that there must be an active process, which leads to the change in zone 2. The regressive development of the centrally demarcated fibrillar bundle (target) is regarded as secondary degeneration following interruption of the nutritional supply.

Entities:  

Mesh:

Year:  1976        PMID: 936976     DOI: 10.1007/bf00690557

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  ORTHOGONAL DIAMETERS IN THE ANALYSIS OF MUSCLE FIBRE SIZE AND FORM.

Authors:  S K SONG; N SHIMADA; P J ANDERSON
Journal:  Nature       Date:  1963-12-21       Impact factor: 49.962

2.  Measurement of voluntary muscle fiber cross sections: a comparative study of different possible methods.

Authors:  H P Schmitt
Journal:  Microsc Acta       Date:  1976-01

3.  A rapid one-step Mallory-Heidenhain stain for connective tissue.

Authors:  J E CASON
Journal:  Stain Technol       Date:  1950-10

4.  [Ultrastructure of "target fibers"].

Authors:  M Tomonaga; E Sluga
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1969

5.  Histochemical studies of denervated or tenotomized cat muscle: illustrating difficulties in relating experimental animal conditions to human neuromuscular diseases.

Authors:  W K Engel; M H Brooke; P G Nelson
Journal:  Ann N Y Acad Sci       Date:  1966-09-09       Impact factor: 5.691

6.  [Histo-enzymatic studies of muscle. I. In proximal neurogenic amyotrophy (Kugelberg-Welander)].

Authors:  L Martin; J Reniers
Journal:  Acta Neuropathol       Date:  1967-11-29       Impact factor: 17.088

7.  An electron microscopic study of target fibers, target-like fibers and related abnormalities in human muscle.

Authors:  D L Schotland
Journal:  J Neuropathol Exp Neurol       Date:  1969-04       Impact factor: 3.685

8.  The relationship between target, targetoid, and targetoid/core fibers in severe neurogenic muscular atrophy.

Authors:  H P Schmitt; B Volk
Journal:  J Neurol       Date:  1975-09-22       Impact factor: 4.849

9.  An electron-microscope study of muscle degeneration and vascular changes in polymyositis.

Authors:  S A Shafiq; A T Milhorat; M A Gorycki
Journal:  J Pathol Bacteriol       Date:  1967-07

10.  "Epi-" and intramedullary neurilemmoma of the spinal cord with denervation atrophy in the related skeletal muscles.

Authors:  H P Schmitt
Journal:  J Neurol       Date:  1975-08-01       Impact factor: 4.849

View more
  4 in total

1.  Quantitative analysis of the size distribution of target- and targetoid fibres employing the method of Daeves and Beckel for mixed distributions.

Authors:  H P Schmitt
Journal:  Acta Neuropathol       Date:  1979-03-15       Impact factor: 17.088

2.  Splitting of target fibers: myopathic signs in denervation phenomena.

Authors:  H P Schmitt
Journal:  J Neurol       Date:  1977-01-13       Impact factor: 4.849

3.  Target-targetoid phenomenon of the human muscle fibers. A histological, histochemical and ultrastructural study.

Authors:  S Yagishita; Y Itoh
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-08-09

4.  [Hypertrophy of the transversal tubular system in target fibres. An electron microscopic study (author's transl)].

Authors:  B Volk
Journal:  Acta Neuropathol       Date:  1977-04-29       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.